Skandinaviska Enskilda Banken Ab (Publ) Care Dx, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$20.49 - $39.72 $220,226 - $426,910	10,748 Added 89.16%	22,803 $490,000
Q1 2022 May 11, 2022	SELL	$28.19 - $46.6 $168,632 - $278,761	-5,982 Reduced 33.17%	12,055 $446,000
Q3 2021 Nov 10, 2021	SELL	$59.15 - $91.99 $174,669 - $271,646	-2,953 Reduced 14.07%	18,037 $1.14 Million
Q2 2021 Aug 10, 2021	BUY	$63.02 - $95.11 $37,118 - $56,019	589 Added 2.89%	20,990 $1.92 Million
Q1 2021 May 14, 2021	SELL	$57.62 - $95.6 $627,251 - $1.04 Million	-10,886 Reduced 34.79%	20,401 $1.39 Million
Q4 2020 Feb 11, 2021	BUY	$41.43 - $77.09 $1.3 Million - $2.41 Million	31,287 New	31,287 $2.27 Million

219

53.2M

53.5K

23.9K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $942M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.